Captrust Financial Advisors Makes New $392,000 Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Captrust Financial Advisors purchased a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, Holdings Channel reports. The institutional investor purchased 2,944 shares of the company’s stock, valued at approximately $392,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Martingale Asset Management L P lifted its position in shares of Addus HomeCare by 1.8% during the third quarter. Martingale Asset Management L P now owns 27,381 shares of the company’s stock worth $3,642,000 after acquiring an additional 482 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Addus HomeCare by 7.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 33,915 shares of the company’s stock valued at $4,512,000 after purchasing an additional 2,458 shares during the period. MetLife Investment Management LLC lifted its holdings in Addus HomeCare by 8.9% during the 3rd quarter. MetLife Investment Management LLC now owns 9,934 shares of the company’s stock worth $1,322,000 after purchasing an additional 814 shares in the last quarter. CreativeOne Wealth LLC bought a new position in Addus HomeCare in the 3rd quarter worth about $887,000. Finally, Glenmede Trust Co. NA purchased a new position in Addus HomeCare during the 3rd quarter valued at about $491,000. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of recent analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Stephens raised their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. KeyCorp began coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. Finally, Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Up 2.5 %

ADUS opened at $125.00 on Friday. The business’s fifty day simple moving average is $125.64 and its 200 day simple moving average is $124.37. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The stock has a market cap of $2.27 billion, a PE ratio of 28.60, a P/E/G ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.03 earnings per share. As a group, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.